The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly PG Van Buynder, S Konrad, JL Van Buynder, E Brodkin, M Krajden, ... Vaccine 31 (51), 6122-6128, 2013 | 180 | 2013 |
Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease M Bigham, R Copes Drug Safety 28, 89-101, 2005 | 121 | 2005 |
Public health and hepatitis C DM Patrick, JA Buxton, M Bigham, RG Mathias Canadian Journal of Public Health/Revue Canadienne de Sante'e Publique, S18-S21, 2000 | 70 | 2000 |
Hepatitis E in Canadian blood donors MA Fearon, SF O'Brien, G Delage, V Scalia, F Bernier, M Bigham, ... Transfusion 57 (6), 1420-1425, 2017 | 49 | 2017 |
Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students DM Patrick, M Bigham, H Ng, R White, A Tweed, DM Skowronski The Pediatric infectious disease journal 22 (10), 874-878, 2003 | 45 | 2003 |
Neisseria meningitidis Carriage during an Outbreak of Serogroup C Disease DM Patrick, S Champagne, SH Goh, G Arsenault, E Thomas, C Shaw, ... Clinical infectious diseases 37 (9), 1183-1188, 2003 | 42 | 2003 |
Uptake and behavioural and attitudinal determinants of immunization in an expanded routine infant hepatitis B vaccination program in British Columbia M Bigham, VP Remple, K Pielak, C McIntyre, R White, W Wu Canadian Journal of Public Health 97, 90-95, 2006 | 40 | 2006 |
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America AJ Pollard, J Ochnio, M Ho, M Callaghan, M Bigham, S Dobson Emerging infectious diseases 10 (10), 1812, 2004 | 37 | 2004 |
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013 M Murti, M Krajden, M Petric, J Hiebert, F Hemming, B Hefford, M Bigham, ... Eurosurveillance 18 (49), 20649, 2013 | 32 | 2013 |
Potential Capsule Switching from Serogroup Y to B: The Characterization of Three such Neisseria meningitidis Isolates Causing Invasive Meningococcal Disease … RSW Tsang, DKS Law, SD Tyler, GS Stephens, M Bigham, WD Zollinger Canadian Journal of Infectious Diseases and Medical Microbiology 16, 171-174, 2005 | 32 | 2005 |
Diffuse lamellar keratitis complicating laser in situ keratomileusis: post-marketing surveillance of an emerging disease in British Columbia, Canada, 2000–2002 M Bigham, CL Enns, SP Holland, J Buxton, D Patrick, S Marion, ... Journal of Cataract & Refractive Surgery 31 (12), 2340-2344, 2005 | 27 | 2005 |
Relation between hospital HIV/AIDS caseload and mortality among persons with HIV/AIDS in Canada RS Hogg, J Raboud, M Bigham, JSG Montaner Clinical and investigative medicine 21 (1), 27, 1998 | 26 | 1998 |
Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods A Blasig, EC Wagner, D Pi, M Bigham, VP Remple, KJP Craib, P Doyle, ... Canadian journal of public health 102, 98-102, 2011 | 24 | 2011 |
Modelling the costs and effects of a universal infant immunization program using conjugated pneumococcal vaccine in British Columbia. D Moore, M Bigham, D Patrick | 24 | 2003 |
Exposure to thimerosal in vaccines used in Canadian infant immunization programmes, with respect to risk of neurodevelopmental disorders. M Bigham, R Copes, L Srour | 23 | 2002 |
Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism? B Strauss, M Bigham | 22 | 2001 |
An outbreak of mumps among young adults in Vancouver, British Columbia, associated with ‘rave’parties J Buxton, C Craig, P Daly, M Bigham, A Bell, M Fyfe Canadian journal of public health 90, 160-163, 1999 | 19 | 1999 |
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study J Van Schalkwyk, M Nourmoussavi, A Massey, R Gustafson, E Brodkin, ... Canadian Journal of Gastroenterology and Hepatology 28, 525-528, 2014 | 17 | 2014 |
Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women M Dawar, DM Patrick, M Bigham, D Cook, M Krajden, H Ng CMAJ 168 (6), 703-704, 2003 | 15 | 2003 |
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections: summary RR Sharma, M Lozano, M Fearon, M Bigham, R Djoudi, P Gallian, ... Vox sanguinis 112 (4), 388-396, 2017 | 14 | 2017 |